Orgenesis subsidiary MaSTherCell Global expanding into the US

Orgenesis Inc (NASDAQ:ORGS) subsidiary MaSTherCell Global CEO Derran Head tells Proactive Investors MaSTherCell is expanding into the US and building a new 30,000-square-foot manufacturing facility in Houston.

The Germantown, Maryland-based company’s subsidiary MaSTherCell Global is a leading cell and gene therapy global contract development and manufacturing organization, or CDMO.

Quick facts: Orgenesis

Price: $4.50

Market: NASDAQ
Market Cap: $72.63 m


e-Therapeutics’ Barlow hails deals with Novo Nordisk and ‘top five pharma...

Ray Barlow, chief executive of e-Therapeutics (LON:ETX), talks to Proactive’s Andrew Scott about the company’s unique approach to drug discovery, which uses computational techniques to find potential breakthrough new treatments. He also provided some insight into recent tie-ups with Denmark’s...

4 days, 2 hours ago

2 min read